You have no items in your shopping cart.
You have no items in your shopping cart.
Catalog Number | orb1089428 |
---|---|
Category | Small Molecules |
Description | Capmatinib, also known as INCB28060 and INC280, is an orally bioavailable inhibitor of the proto-oncogene c-Met with potential antineoplastic activity. c-Met inhibitor INC280 selectively binds to c-Met, thereby inhibiting c-Met phosphorylation and disrupting c-Met signal transduction pathways. This may induce cell death in tumor cells overexpressing c-Met protein or expressing constitutively activated c-Met protein. Capmatinib was approved in 2020. |
CAS Number | [1865733-40-9] |
MW | 503.356245756149 |
SMILES | FC1=C(C(NC)=O)C=CC(=C1)C1C=NC2=NC=C(CC3C=CC4=C(C=CC=N4)C=3)N2N=1.Cl.Cl.O |
Formula | C23H21CL2FN6O2 |
Note | For research use only |
Expiration Date | 12 months from date of receipt. |